Cycle Pharmaceuticals Competitors, Revenue, Alternatives and Pricing
Estimated Revenue & Financials
- Cycle Pharmaceuticals's estimated annual revenue is currently $10.1M per year.
- Cycle Pharmaceuticals's estimated revenue per employee is $201,000
- Cycle Pharmaceuticals's total funding is $25M.
- Cycle Pharmaceuticals has 50 Employees.
- Cycle Pharmaceuticals grew their employee count by 43% last year.
- Cycle Pharmaceuticals currently has 1 job openings.
What Is Cycle Pharmaceuticals?
Innovation. Transformation. Treatment, reimagined. We reimagine how orphan drugs can benefit patients with rare diseases, to make their lives easier and improve their quality of life at every stage. By optimising and enhancing treatments, improving efficacy, identifying new indications for drugs, and reintroducing products to the market, we give patients the options they need. Cycle has three core areas of pharmaceutical development: improving drugs ￃﾢ￢ﾂﾬ￢ﾀﾜ optimising an existing drug; repurposing drugs ￃﾢ￢ﾂﾬ￢ﾀﾜ creating a new indication for an already existing drug; and generics ￃﾢ￢ﾂﾬ￢ﾀﾜ reinstating generic drugs, previously available in the market. These three areas of focus are underpinned by formulation technology ￃﾢ￢ﾂﾬ￢ﾀﾜ creating new drug delivery technologies to improve the efficacy and effectiveness of drugs, allowing us to give patients greater freedom and choice.keywords:N/A